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Abstract
Rhodomyrtone, purified from Rhodomyrtus tomentosa (Aiton) Hassk, exhibits a high degree of potency against methicillin-
resistant Staphylococcus aureus (MRSA). We recently demonstrated that exposure of MRSA to a subinhibitory concentration
(0.174 mg/ml) of rhodomyrtone resulted in the alteration of expression of several functional classes of bacterial proteins. To
provide further insight into the antibacterial mode of action of this compound, we determined the impact of exposure to
rhodomyrtone on the gene transcriptional profile of MRSA using microarray analysis. Exposure of MRSA to subinhibitory
concentrations (0.5MIC; 0.5 mg/ml) of rhodomyrtone revealed significant modulation of gene expression, with induction of
64 genes and repression of 35 genes. Prominent changes in response to exposure to rhodomyrtone involved genes
encoding proteins essential to metabolic pathways and processes such as amino acid metabolism, membrane function,
ATP-binding cassette (ABC) transportation and lipoprotein and nucleotide metabolism. Genes involved in the synthesis of
the aspartate family of amino acids, in particular proteins encoded by the dap operon were prominent. The
diaminopimelate (DAP) biosynthetic pathway is the precursor of lysine synthesis and is essential for peptidoglycan
biosynthesis. However, phenotypic analysis of the peptidoglycan amino acid content of rhodomyrtone-treated MRSA did
not differ significantly from that extracted from control cells. Genes involved in the biosynthesis of amino acids and
peptidoglycan, and a high affinity ATP-driven K (+) transport system, were investigated by quantitative reverse transcription-
PCR (qRT-PCR) using EMRSA-16 1, 4, or 18 h after exposure to rhodomyrtone and in general the data concurred with that
obtained by microarray, highlighting the relevance of the DAP biosynthetic pathway to the mode of action of
rhodomyrtone.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a major
cause of hospital- and community-acquired infections [1,2] and
continues to evolve with respect to the emergence of resistance to
commonly used antibiotic classes [3]. Linezolid, quinupristin-
dalfopristin, daptomycin, telavancin, new glycopeptides, and
ceftobiprole are new antimicrobial agents which have been
introduced or are under clinical development for the treatment
of infections due to drug resistant bacteria [4,5] but resistance to
these agents is, in turn, emerging [6,7,8,9]. Thus, there is
a continuing need to discover and develop new therapeutic agents
to combat these ememrging drug-resistant bacteria [10]. Natural
bioactive compounds and medicinal plants have been successfully
used in the treatment of several bacterial infections [11,12,13] and
may continue to provide a source of much-needed new agents to
replenish our dwindling antibacterial armamentarium.
Rhodomyrtus tomentosa (Aiton) Hassk. is an ornamental evergreen
shrub of the family Myrtaceae. It is native to Southeast Asia and is
a troublesome invader of native plant communities in Florida.
Crude extracts from leaves of this plant possess good antibacterial
efficacy against Escherichia coli and S. aureus [14] and at least part of
this activity is attributable to rhodomyrtone, an acylphloroglucinol
derivative [15]. The compound has been shown to possess
significant antibacterial activity against several Gram-positive
bacteria such as Bacillus subtilis, Enterococcus faecalis, S. aureus, S.
epidermidis, Streptococcus spp., and MRSA [14,16,17,18].
We have recently undertaken a proteomic analysis of MRSA
challenged with subinhibitory concentrations of rhodomyrtone;
the compound modulates expression of a number of proteins
involved in cell wall biosynthesis, cell division, stress responses and
cell surface antigen and virulence factor expression, as well as
metabolic pathways mediating amino acid metabolism [18]. In
addition, transmission electron micrographs of rhodomyrtone-
treated MRSA revealed pronounced damage to the cell envelope
and the septum in the abence of any perturbation of the amino
acid content of the peptidoglycan-wall teichoic acid complex [18].
We were, however, unable to identify the primary target for
rhodomyrtone within MRSA. Here, we report global transcrip-
tional responses of EMRSA-16 after 1 h exposure to rhodomyr-
tone. Time course analysis of the bacterial transcriptome after
exposure to the compound for 1, 4, and 18 h was undertaken by
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the quantitative real time-polymerase chain reaction (qRT-PCR).
Genome expression profiling of MRSA with and without
rhodomyrtone will provide an opportunity to gain insights into
the mechanism of action of the compound.
Results and Discussion
Rhodomyrtone-induced Changes in Gene Expression
The global transcriptional response of MRSA to rhodomyrtone
using a S. aureus microarray for the profiling of genes modulated by
this agent. The minimum inhibitory concentration (MIC) and
minimum bactericidal concentration (MBC) of rhodomyrtone
against EMRSA-16 by broth microdilution were 1.0 mg/ml and
4.0 mg/ml, respectively. The microarray analysis was designed to
investigate the effects of rhodomyrtone at 0.5MIC (0.5 mg/ml) on
gene expression of EMRSA-16 after a short incubation period of
1 h. Transcript abundance from mid log-phase cells grown in
MHB in the presence or absence of rhodomyrtone were compared
by Affymetrix microarray analysis. Microarray data were further
validated by quantitative real-time reverse transcriptase-poly-
merase chain reaction (qRT-PCR) analysis of selected genes.
Statistically significant twofold or greater changes were demon-
strated for 64 rhodomyrtone-induced genes and 35 rhodomyrtone-
repressed genes (Tables S1 and S2). Up- and down-regulated
genes were categorized into three groups: (i), ,10 fold change, 61
genes (61.6%), (ii), 10–50 fold change, 22 genes (22.2%), and (iii)
.50 fold change, 16 genes (16.2%). Genes up-regulated by growth
in MHB containing rhodomyrtone included genes involved in the
metabolism of amino acids, putative membrane proteins, trans-
porter proteins, lipoproteins, exported proteins, nucleotide me-
tabolism, virulence factors and cell wall metabolism.
Rhodomyrtone strongly up-regulated a group of genes involved
in amino acid biosynthetic pathways; these included genes
encoding proteins involved in lysine, threonine and arginine
biosynthesis, such as aspartate semialdehyde dehydrogenase (asd),
dihydrodipicolinate synthase (dapA), dihydrodipicolinate reductase
(dapB), and tetrahydrodipicolinate (dapD),threonine synthase (thrC),
and putative argininosuccinate synthase (argG). Diaminopimelate
(DAP) biosynthetic pathway produces not only the precursors for
methionine, homoserine, threonine, lysine biosynthesis, but also
for the other amino acids such as arginine and proline, all of which
are essential for cell cycle and metabolism. Therefore, it is possible
that the await-to-be elucidated antibacterial mechanism of
rhodomyrtone lies in there. Based on structure comparison,
rhodomyrtone showed no similarities with DAP, any of its
biosynthetic precursors, or intermediate products of methionine,
homoserine, threonine, and lysine biosynthesis pathway. There-
fore, rhodomyrtone is unlikely to act as amino acid analog for its
antibacterial mechanism. However, whether it interferes with
enzymes in these biosynthetic pathways is still under investigation.
DAP biosynthesis is an attractive target for the development of
antibacterial drugs as it is essential for peptidoglycan biosynthesis
and DAP is not required by humans [24,25]. In this study,
microarray data revealed an up-regulation of a group of genes in
the DAP operon. The essential nature of bacterial DAP bio-
synthesis is determined by its absolute requirement as a component
of peptidoglycan and its role as a direct precursor of lysine [26].
Thus, rhodomyrtone may impact on the generation of lysine and
the structural integrity of peptidoglycan. Transcriptomic data also
revealed an increase in transcription of the tagG genes responsible
for teichoic acid biosynthesis [27].
The up-regulation of four ATP-binding cassette (ABC)
transporters and related genes indicated potential modulation of
genes involved in the export of toxins across the cytoplasmic
membrane. Moreover, rhodomyrtone affected several genes
encoding bacterial membrane proteins: seven (10.6%) genes were
strongly induced whereas five (13.9%) genes were weakly down-
regulated.
Two genes, including SAR2030 (encoding MHC class II analog)
and sbi (encoding IgG-binding protein) involved in virulence
determination, were up-regulated. Major histocompatibility com-
plex (MHC) class II analog, the bacterial protein analog to
eukaryotic MHC classII molecules, and IgG binding protein, may
interfere with host immune defenses [28]. Up to 20 genes encoding
hypothetical proteins were up-regulated (30.3%) while four
hypothetical proteins were down-regulated (11.1%). Interestingly,
a gene encoding the conserved hypothetical protein SAR0996 was
the most prominently up-regulated gene (up to 97.3 fold).
Moreover, the data revealed that two ORF transcripts of unknown
function (SAR0437 and SAR0761) showed large increases in
expression (.30 fold) after exposure to rhodomyrtone and may
feature in the primary mode of action of the compound. A more
detailed examination of these gene responses will be clarified in
further studies.
EMRSA-16 genes down-regulated by rhodomyrtone fell into
a number of functional categories that included those involved in
nucleotide and amino acid metabolism and also membrane and
transporter proteins. A phosphor transferase system (PTS) gene,
mtlA, was expressed at a markedly decreased level (12.44-fold
reduction). The gene encoding L-lactate dehydrogenase 1, ldh1,
was down-regulated more than 15-fold by rhodomyrtone. This
gene is involved in pyruvate utilization, converting pyruvate to
lactate. A number of genes related to nucleotide metabolism were
down-regulated by rhodomyrtone, including DNA gyrase subunit
B genes (gyrB), DNA polymerase III subunit delta’ (holB), purine
operon repressor (purR), transcription antitermination protein
(nusG), DNA-directed RNA polymerase beta chain protein (rpoB),
succinate dehydrogenase cytochrome b558 (sdhC), ribosomal large
subunit pseudouridine synthase B (rluB), tRNA-specific 2-thiour-
idylase Mnm (mnmA), queuine tRNA-ribosyltransferase putative
methyltransferase (tgt), RNA polymerase sigma-B factor (sigB),
transcription termination factor (rho), tRNA (guanine-N(7)-)-
methyltransferase (trmB) and tRNA pseudouridine synthase A
(truA).
Quantitative Reverse Transcription-polymerase Chain
Reaction (qRT-PCR)
Fourteen gene-specific primers were used, including (i), ten
genes identified by microarray analysis as modulated by
rhodomyrtone, asd, dapA, kdpF, thrC, scdA, SAR0996, SAR0437,
SAR0761, sigB, and rpoB, and (ii), four genes adopted as negative
controls, lysA, ftsH, ftsZ, and murE, that were not differentially
expressed by rhodomyrtone (Table 1). Gene expression data
obtained for asd, dapA, thrC, SAR0996, SAR0437, SAR0761, sigB,
and rpoB were similar for both microarray analysis and qRT-PCR,
even though the fold change values of most genes obtained from
qRT-PCR were lower than those obtained by microarray analysis.
A time course analysis of 14 genes by qRT-PCR of EMRSA-16
exposed to rhodomyrtone for 1, 4, and 18 h was carried out
(Figure 1). After 1 and 4 h exposure, asd and dapA, involved in the
DAP biosynthetic pathway, and the threonine pathway gene thrC
were up-regulated. After incubation for 18 h, there was no
significant change in expression of asd and thrC while dapA
continued to be over-expressed but at a lower level than after 1
and 4 h incubation. lysA, encoding meso-DAP-decarboxylase, was
down-regulated at the 1 h timepoint and there was no significant
change after incubation for 4 and 18 h. Down-regulation of gene
expression after 1 h treatment with rhodomyrtone for 1 h was
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observed in genes involved in bacterial cell wall biosynthesis and
cell division, including ftsH, ftsZ, murE, and rpoB; rpoB encodes the
b subunit of RNA polymerase. Mutation of rpoB results in
repression of urease genes and up- and downregulation of genes
involved in cell wall biosymthesis and cell membrane metabolism
[29]. rpoB remained under-expressed after 4 h exposure to the
agent but was digfferentially expressed by 18 h. At 1 h, only murE
was up-regulated (.19 fold); ftsZ and rpoB were down-regulated
and ftsZ and scdA were unchanged. ftsH, ftsZ, and scdA was down-
regulated while levels of murE RNA were not significantly different
after 18 h incubation with rhodomyrtone. Coordinated cell wall
metabolism is critical for bacterial cell integrity, playing a signif-
icant role in the determination of cell shape and cell division, in
resistance to external stress conditions such as osmotic pressure,
and the wall is involved in host-pathogen interactions [30].
Microarray data revealed scdA to be 5.14-fold up-regulated
following exposure to rhodomyrtone at 0.5 mg/ml for 1 h.
Scanning electron microscopy (SEM) revealed no abnormalities
with respect to morphology, probably reflecting the shorter time
intervals for changes in gene expression in comparison to those
required for manifestation of phenotypic changes. scdA encodes the
cell wall biosynthesis protein Scd, which plays an important role in
staphylococcal cell division and cell wall turnover. Mutation of this
gene has revealed dramatic changes in morphology characterized
by aberrant placement of septa [31]. Proteome analysis data from
previous studies on a clinical MRSA strain indicated down-
regulation of ScdA following rhodomyrtone treatment at
0.174 mg/ml for 18 h [18]. However, qRT-PCR revealed no
obvious changes in scdA expression. After 1 h incubation, murE
gene did not appear to be modulated when bacteria were
subjected to microarray analysis but was significantly up-regulated
when qRT-PCR was employed. murE encoding the UDP-N-
acetylmuramoyl-L-alanyl-D-glutamate:meso-diaminopimelate li-
gase and is a essential enzyme in the assembly of the stem peptide
of peptidoglycan [32]. The gene encoding the cell division protein
FtsZ was not modulated as determined by microarray but was
significantly down-regulated 1 h after challenge with rhodomyr-
tone by qRT-PCR. Figure 2 summarises rhodomyrtone-induced
changes, after I h exposure of MRSA, in the expression of genes of
the aspartate pathway. sigB is key to the regulation of stress
responses enabling survival under stresses induced by antibiotics
and host bactericidal factors. In this study, sigB was down-
regulated after treatment at all time-points, indicating responses of
the bacteria to environmental stresses.
Genes of unknown function (encoding hypothetical proteins),
including SAR0996 (encoding conserved hypothetical protein),
SAR0437 (encoding putative exported protein), and SAR0761
(encoding putative lipoprotein), were highly up-regulated at the 1
and 4 h time points. After 18 h, down-regulation of SAR0996 and
SAR0437 was evident while SAR0761 showed no change. Such
genes may be relevant to the mode of action of rhodomyrtone in
MRSA, as substantial changes in expression were observed at all
three time points. We will undertake the characterization of these
genes in order to shed light on the mechanism of action of the
bioactive compound.
SEM
EMRSA-16 was incubated for 1 and 4 h with rhodomyrtone at
a concentration of 0.5MIC (0.5 mg/ml) and the cells examined by
SEM. No obvious differences in bacterial morphology and cell
surface architecture between rhodomyrtone-treated cells and
the untreated control were observed at either time point
(Figure 3A–3B).
Effects on Amino Acid Composition of Peptidoglycan
To determine if the addition of rhodomyrtone at 0.5MIC
caused modification of the murein structure of MRSA in terms of
amino acid composition, peptidoglycan from EMRSA-16 cells
grown in MHB supplemented with rhodomyrtone for 4 h was
purified, analyzed and compared to material extracted from
untreated control cells. Cell wall amino acids were quantified by
reversed phase high-performance liquid chromatography (HPLC).
Molar mass ratios of peptidoglycan-derived amino acids, glycine,
alanine, and lysine, were normalized with respect to glutamic acid.
No obvious differences in murein amino acid content were
identified when rhodomyrtone-treated cells and untreated controls
were compared, suggesting that rhodomyrtone did not affect
muropeptide composition of the bacterial peptidoglycan (Table 2).
In summary, microarray analysis demonstrated that rhodomyr-
tone induces changes in gene transcription of MRSA. Thus, genes
involved in the biosynthesis of amino acids, in particular those of
the diaminopimelate biosynthetic pathway, in the biogenesis of the
cell envelope, in transporter proteins and in nucleotide metabolism
Table 1. Oligonucleotide primers used for qRT-PCR analysis.
Primer targeta Nucleotide sequence (59 to 39)b
asd F CAAGTCAATGGCGTATGG
R GGCACAACAGACTGAATC
dapA F ACTACTGCTGAGAGCCCTAC
R GTTCCAGTTCCAGCTATGAC
ftsH F TAGAGCGGTTGCAGGTGAAG
R ACCACGTTGACGACCAACAG
ftsZ F TTACTGGTGGCGAGTCATTG
R TTTACGCTTGTTCCGAATCC
kdpF F GAGGCGTTAAGCTATCATGC
R CATGGAGCGAATATGGAAGG
lysA F TTAGACTGCCGGTATCTTGG
R CAATAACGTCGCCTGTACTG
murE F TGATTCACGTACAGCGAGAG
R CTTAATGTGTCCGGCACAAC
rpoB F CGCCTAAAGGTGTAACTGAG
R GATAATGTGTCGTCGCCTTC
SAR0996 F GAAGCGTTTGTCACAACC
R ATTGACGAGTGCGTCATC
SAR0437 F CCGTCTTGCTTAGCTTTG
R GAAGCAGATGCGAAAGTG
SAR0761 F TTAATTTAGCGCCGCCGAAG
R TCGCAATGGTTGACTACG
scdA F AGCAAGGTGAGGTAGTAGAC
R AGTACCACACGCTTCTATCG
sigB F GCCGTTCTTTGAAGTCTG
R TATCTGATCGCGAACGAG
thrC F TTTGGCTTCCAAGCTGAAGG
R TCCCAACTAGCAGGATTACC
16s rRNA F GACGGTCTTGCTGTCACTTA
R AGTTCCAGTGTGGCCGATCA
aBased on the annotation of MRSA252 genome.
bForward (F) and reverse (R) primers.
doi:10.1371/journal.pone.0045744.t001
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were significantly modulated. Genes encoding the hypothetical
proteins SAR0996, SAR0437, and SAR0761 were highly up-
regulated and we intend to examine their potential role in the
antibacterial action of rhodomytrone.
Materials and Methods
Purification of Rhodomyrtone
The purification and structural elucidation of rhodomyrtone,
a major bioactive principle from the leaf of R. tomentosa, have been
previously published by our research group [15,16]. The purity of
rhodomyrtone has been confirmed by nuclear magnetic resonance
and mass spectrometry [14,16]. Rhodomyrtone was dissolved in
100% dimethyl sulphoxide (DMSO) prior to addition to Mueller
Hinton broth (MHB, Oxoid). Bacterial cultures serving as
untreated controls contained DMSO but not rhodomyrtone.
Bacterial Strains, Growth Conditions, and Antibacterial
Susceptibility
Epidemic MRSA isolate EMRSA-16 was from a clinical sample
obtained at the Royal Free Hospital, London, UK [19]. The
bacteria were grown without shaking in MHB at 37uC. MIC was
determined by broth microdilution method according to Clinical
and Laboratory Standards Institute procedures [20]. In brief,
twofold serial dilutions of rhodomyrtone in a 96-well microtiter
plate were prepared in MHB to obtain a concentration range of
0.0625 to 128 mg/ml. Exponential phase bacteria were added to
each well to give an inoculum of 56105 cfu/ml in a total volume of
200 ml. After incubation at 37uC for 16–18 h, the extent of
inhibition of bacterial growth was determined using a spectropho-
tometer against a blank well (MHB containing 1% DMSO). MIC
was defined as the lowest concentration of the agent that
completely inhibited bacterial growth. For each assay, three
independent experiments were performed in triplicate.
Figure 1. Time course analysis of gene expression in MRSA following exposure to rhodomyrtone. RNA samples were extracted from
rhodomyrtone-treated cells (0.5 mg/ml, 0.5MIC) after incubation for 1 h, 4 h, and 18 h. Gene expression levels were normalized to 16s rRNA (p-value
of #0.05).
doi:10.1371/journal.pone.0045744.g001
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Preparation of RNA
Total RNA was extracted using FastRNAH Pro Blue kit (Q-
biogen, UK) according to the manufacturer’s instruction. For
microarray analysis, an overnight culture of EMRSA-16 was
added to fresh MHB to provide an initial inoculum of
approximately 106 cfu/ml. Bacterial cultures were incubated at
37uC to exponential phase (optical density at 600nm= 0.15).
Rhodomyrtone was added to the cultures to give a final
concentration of 0.5 mg/ml. The same concentration of DMSO
used in rhodomyrtone-treated cells was added to the untreated
control. The cultures were incubated at 37uC for 1, 4, or 18 h.
The bacterial pellets of each time point were collected by
centrifugation at 8,0006g for 30 min and washed twice with
phosphate buffer saline (PBS). A double volume of RNAprotect
Bacteria Reagent (QIAGEN, UK) was added to the pellets. The
mixture was incubated at room temperature for 5 min and the
bacterial cells centrifuged (3,5006g; 4uC; 10 min). Total RNA was
extracted from the bacteria using the manufacturer’s ‘‘Fast prep’’
protocol for the RNeasy Mini-Prep Kit (QIAGEN, UK). The
bacterial DNA was removed by DNase digestion steps with
RNase-free DNase (QIAGEN, UK) and RNA further purified
using RNeasy Mini protocol. RNA quality and quantity was
determined by agarose gel electrophoresis, NanoDrop 2000
spectrophotometer (Nanodrop Technologies), and Bioanalyzer
2100 (Agilent Technologies). All samples were stored at -80uC
until required.
Microarray and Data Analysis
The microarray analysis used in this study has been previously
described by Doyle et. al. [21]. The array contains PCR products
representing all predicted open reading frames from the initial
seven S. aureus genome sequencing projects [22]. The array design
is available in BmG@Sbase (Accession No. A-BUGS-17; http://
bugs.sgul.ac.uk/A-BUGS-17) and also ArrayExpress (Accession
No. A-BUGS-17). RNA isolated from bacteria exposed to
rhodomyrtone for 1 h was transcribed into cDNA and concom-
itantly labeled by incorporation of Cy3 and Cy5 (GE Healthcare)
using superscript III reverse transcriptase (Invitrogen, UK). cDNA
was purified using MinElute kit (QIAGEN, UK), the probes
pooled, hybridized overnight to the S. aureus microarray at 65uC
and subjected to stringent washing. Hybridization data was
analyzed by Affymetrix 428 scanner and quantified using Bluefuse
for Microarrays 3.5 software (BlueGnome). Data analysis was
performed in GeneSpring GX 7.3 (Agilent Technologies) by
median-normalized Cy5/Cy3 ratio intensity for three biological
replicates. Only genes whose expression ratio showed at least two-
fold difference with Benjamini and Hochberg false discovery rate
#0.05% in the presence of rhodomyrtone were regarded as being
significantly different from the control. Fully annotated microarray
data have been deposited in BmG@Sbase (accession number E-
BUGS-136; http://bugs.
sgul.ac.uk/E-BUGS-136) and also ArrayExpress (accession
number E-BUGS-136). Microarray analysis data were further
validated by qRT-PCR.
qRT-PCR
The reaction was performed on cDNA generated from RNA
samples collected after 1, 4, or 18 h incubation. qRT-PCR was
carried out using Brilliant II SYBRH Green qRT-PCR one-step kit
(Stratagene). The reaction was run in Rotor gene 3000 (Corbett
Research) using the primers listed in Table 1. The condition
applied for PCR was 95uC for 10 min, followed by 55 cycles of
95uC for 30 s, 57uC for 30 s, and 72uC for 30 s. The comparative
threshold method was used to determine relative quantification of
mRNA abundance. Changes in mRNA expression level were
calculated after normalization to the internal control, 16S rRNA
bacterial house-keeping gene.
SEM
EMRSA-16 cells were collected by centrifugation (8,0006g at
4uC for 5 min) following exposure to rhodomyrtone at a concen-
tration of 0.5 mg/ml for 1 or 4 h. The cells were washed twice with
PBS and fixed in 1.5% glutaraldehyde for at least 2 h at room
temperature. Samples were washed once with 70% ethanol, twice
Figure 2. Schematic representation of the diaminopimelate (DAP) pathway in staphylococci. The pathway depicts expression of DAP
biosynthesis related genes induced or reduced in rhodomyrtone-treated MRSA after 1 h incubation. Gray boxes: genes that were significantly
represented by microarray; pink boxes: genes that were significantly represented by qRT-PCR. Blue arrow and red arrow represented an increase or
decrease in expression fold change, respectively.
doi:10.1371/journal.pone.0045744.g002
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with 100% ethanol, air dried, and adhered to a SEM stub using
double sided carbon adhesive discs (Taab Laboratories). The
samples were gold-coated using a Q150T Sputter Coater
(Quorum Technologies) and viewed with a FEI Quanta 200
FEG Scanning Electron Microscope and an accelerating voltage of
5 kV.
Isolation of Peptidoglycan
Peptidoglycan was extracted and purified by a modification of
the method described by Stranden and coworkers [23]. Briefly,
logarithmic phase bacteria were inoculated into MHB containing
0.5 mg/ml of rhodomyrtone and incubated for 4 h at 37uC. The
cells were rapidly chilled, harvested by centrifugation (10,0006g;
4uC; 20 min) and washed with 0.01 M PBS. The bacterial cells
were broken with glass beads (0.2 mm) using a cell homogenizer
(FastPREP FP120, Savant) at a speed setting of 6.0 for 45 s. The
samples were placed on ice for 2 min and centrifuged at 14,1006g
for 5 min. After removal of the supernatant, the cell pellet was
washed with 2 M NaCl. The cell suspension was further washed
with 0.5% SDS and incubated at 60uC for 30 min with stirring to
remove noncovalently bound components. The bacterial cell wall
was isolated by centrifugation at 5,1006g at 25uC for 15 min and
washed with water. Protein A was removed by incubation with
0.2 mg of trypsin per ml in 1 M Tris-HCl (pH 7.2) at 37uC for
24 h. The samples were centrifuged, washed several times with
buffer and water, and then resuspended in 1 ml of 10% (w/vo)
Figure 3. Scanning electron micrographs demonstrate the effect of rhodomyrtone on EMRSA-16 cell morphology. The bacteria were
grown in MHB containing 0.5 mg/ml rhodomyrtone (0.5MIC) and incubated for 4 h (A). Untreated control cultures were grown in MHB supplemented
with DMSO and incubated for 4 h (B). Scale bars = 2 mm.
doi:10.1371/journal.pone.0045744.g003
Table 2. Analysis of amino acid composition of purified
peptidoglycan of EMRSA-16 in the presence or absence of
rhodomyrtone.
Molar mass ratio relative to glutamic acida
Amino acid Rhodomyrtone-treated cells Untreated cells
Alanine 1.70 2.13
Glutamic acid 1.00 1.00
Glycine 3.33 3.94
Lysine 0.97 1.05
aMolar ratios normalized to Glutamic acid = 1.0, based on amino acid
composition and molecular weight.
doi:10.1371/journal.pone.0045744.t002
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aqueous trichloroacetic acid at 4uC for 18 h to remove teichoic
acid. Purified murein was isolated by centrifugation at 14,1006g
for 5 min, washed with water, and lyophilized using Freeze Dryer
(ALPHA 1–2 LDplus, Christ).
Peptidoglycan Amino Acid Analysis
Determination of the amino acid content of peptidoglycan was
preformed by Alta Bioscience (University of Birmingham, UK).
The lyophilized, isolated peptidoglycan was hydrolyzed with 5.8M
HCl under vacuum at 110uC for 24 h. Amino acids were analyzed
in an amino acid analyzer based on Waters HPLC hardware with
sodium citrate buffer system. The amino acids were detected using
ninhydrine reagent.
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